This study was undertaken to investigate whether 68Ga-PSMA-11 PET/CT imaging features extracted from different prostatic zones (zone-1, zone-2, and zone-3) might predict response to androgen deprivation therapy in patients with advanced prostate cancer. The gene discussed is FOLH1; the disease is prostate cancer.